Development of vascular complications and bladder carcinoma in diabetics using pioglitazone: A five-year Indian review

Vallabhajosyula, Saarwaani and Vallabhajosyula, Shashaank and Nair, Suma and Kamath, Asha and Rao, Karthik N (2016) Development of vascular complications and bladder carcinoma in diabetics using pioglitazone: A five-year Indian review. Medical Journal Armed Forces India, 72. pp. 253-257. ISSN 0377-1237

[img] PDF
00003611.pdf - Published Version
Restricted to Registered users only

Download (361kB) | Request a copy

Abstract

Background: Pioglitazone has better cardiovascular outcomes and a questionable relationship with bladder carcinoma in diabetes mellitus, type II (DM-2). We sought to evaluate the role of pioglitazone in the Indian population. Methods: This is a retrospective study at an academic medical center in India. All DM-2 patients in 2008 with a new prescription of pioglitazone were age- and gender-matched with non-users. We excluded patients with gestational DM or DM type I. They were followed forward for five years and demographic data, micro- and macro-vascular complications, mortality, and bladder carcinoma were recorded. Two-tailed p ≤ 0.05 was considered statistically significant. Results: Two cohorts of 260 patients, with mean age of 58 � 11 years with 413 (79.4%) males, were followed for five years. Pioglitazone users had higher hypertension, obesity, DM-2 family history (all p < 0.003), and use of insulin and oral hypoglycemics (all p < 0.0001) in comparison to non-users. HbA1cwas not different between groups. Over five years, pioglitazone users had lesser retinopathy and myocardial infarctions (all p < 0.01). Five cases of bladder carcinoma were noted, all in the pioglitazone group, however without statistical significance. Baseline variables, including mean daily pioglitazone dose, were not statistically different between patients with and without bladder carcinoma. Nephropathy and MI were independent predictors for development of bladder carcinoma within pioglitazone users. Conclusions: Pioglitazone users had significantly lesser myocardial infarctions and retinopathy despitemore difficult to control DM 2. In an age- and gender-matched cohort of users and nonusers, pioglitazone did not contribute to development of bladder cancer in the Indian population.

Item Type: Article
Uncontrolled Keywords: Diabetes mellitus type-2 ; Pioglitazone ; Bladder carcinoma ; Vascular complications ; Thiazolidinedione.
Subjects: Medicine > KMC Manipal > Medicine
Depositing User: KMC Library
Date Deposited: 19 Dec 2017 05:24
Last Modified: 19 Dec 2017 05:24
URI: http://eprints.manipal.edu/id/eprint/150297

Actions (login required)

View Item View Item